Trial intelligence / Profile preview

Elonva in Obese Women for IVF Success

NCT02606500Phase 4Completed

Sponsor
University Medical Centre Ljubljana
Start
Mar 2016
Primary completion
Jan 2017
Modality
rProtein (Recombinant Protein), Hormone, Biologic
Countries
1
01

Overview

Phase 4, open-label trial of corifollitropin alfa in infertility, sponsored by University Medical Centre Ljubljana. Primary endpoint: Number of Oocytes Retrieved Per Patient at 1 month. Started Mar 2016; status: completed.

02

Drugs

corifollitropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02606500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02606500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call